HUP0003984A3 - Process for synthesis of carbocyclyc chloropurine nucleoside analogues - Google Patents

Process for synthesis of carbocyclyc chloropurine nucleoside analogues

Info

Publication number
HUP0003984A3
HUP0003984A3 HU0003984A HUP0003984A HUP0003984A3 HU P0003984 A3 HUP0003984 A3 HU P0003984A3 HU 0003984 A HU0003984 A HU 0003984A HU P0003984 A HUP0003984 A HU P0003984A HU P0003984 A3 HUP0003984 A3 HU P0003984A3
Authority
HU
Hungary
Prior art keywords
carbocyclyc
synthesis
nucleoside analogues
chloropurine nucleoside
chloropurine
Prior art date
Application number
HU0003984A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HUP0003984A2 publication Critical patent/HUP0003984A2/hu
Publication of HUP0003984A3 publication Critical patent/HUP0003984A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU0003984A 1997-10-14 1998-10-14 Process for synthesis of carbocyclyc chloropurine nucleoside analogues HUP0003984A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721780.6A GB9721780D0 (en) 1997-10-14 1997-10-14 Process for the synthesis of chloropurine intermediates
PCT/GB1998/003080 WO1999019327A1 (en) 1997-10-14 1998-10-14 Process for the synthesis of chloropurine intermediates

Publications (2)

Publication Number Publication Date
HUP0003984A2 HUP0003984A2 (hu) 2001-04-28
HUP0003984A3 true HUP0003984A3 (en) 2002-12-28

Family

ID=10820547

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003984A HUP0003984A3 (en) 1997-10-14 1998-10-14 Process for synthesis of carbocyclyc chloropurine nucleoside analogues

Country Status (44)

Country Link
US (1) US6646125B1 (hu)
EP (1) EP1023292B1 (hu)
JP (1) JP4531250B2 (hu)
KR (1) KR100543845B1 (hu)
CN (1) CN1160354C (hu)
AP (1) AP1182A (hu)
AR (1) AR014921A1 (hu)
AT (1) ATE249461T1 (hu)
AU (1) AU738462B2 (hu)
BG (1) BG64597B1 (hu)
BR (1) BR9813048B1 (hu)
CA (1) CA2306958C (hu)
CO (1) CO4980899A1 (hu)
CZ (1) CZ294482B6 (hu)
DE (1) DE69818084T2 (hu)
DK (1) DK1023292T3 (hu)
EA (1) EA003183B1 (hu)
EE (1) EE04059B1 (hu)
EG (1) EG21730A (hu)
ES (1) ES2205553T3 (hu)
GB (1) GB9721780D0 (hu)
GE (1) GEP20022679B (hu)
HK (1) HK1027807A1 (hu)
HR (1) HRP20000216B1 (hu)
HU (1) HUP0003984A3 (hu)
ID (1) ID24927A (hu)
IL (1) IL135323A (hu)
IN (1) IN184590B (hu)
IS (1) IS2195B (hu)
MA (1) MA24676A1 (hu)
MY (1) MY127470A (hu)
NO (1) NO325030B1 (hu)
NZ (1) NZ503679A (hu)
OA (1) OA11370A (hu)
PE (1) PE121899A1 (hu)
PL (1) PL188477B1 (hu)
PT (1) PT1023292E (hu)
RS (1) RS49710B (hu)
SK (1) SK285331B6 (hu)
TR (1) TR200000976T2 (hu)
TW (1) TW436488B (hu)
UA (1) UA54550C2 (hu)
WO (1) WO1999019327A1 (hu)
ZA (1) ZA989338B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ298144B6 (cs) 1997-11-27 2007-07-04 Lonza Ag Zpusob výroby (1S,4R)- nebo (1R,4S)-4-(2-amino-6-chlor-9-H-purin-9-yl)-2-cyklopenten-1-methanolu
FR2849030A1 (fr) * 2002-12-20 2004-06-25 Isochem Sa Procede de preparation des n-(2-amino-4, 6-dihalogenopyrimidin-5-yl) formamides
GB0320738D0 (en) 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
CN100465174C (zh) * 2006-06-13 2009-03-04 中国科学院上海有机化学研究所 制备光学纯阿巴卡韦的方法
KR101109476B1 (ko) * 2009-06-26 2012-01-31 현대제철 주식회사 실린더 교체용 지그장치
KR20170078868A (ko) 2010-01-27 2017-07-07 비이브 헬쓰케어 컴퍼니 항바이러스 치료
CN104672239A (zh) * 2013-11-26 2015-06-03 上海迪赛诺化学制药有限公司 一种采用一锅法制备阿巴卡韦式v中间体的工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
JPS6175A (ja) * 1984-03-06 1986-01-06 ブリストル−マイア−ズ コムパニ− 神経弛緩剤、1‐フルオロフェニルブチル‐4‐(5‐ハロ‐2‐ピリミジニル)ピペラジン誘導体
IT1229531B (it) * 1988-01-20 1991-09-04 Univ Minnesota Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5329008A (en) * 1993-04-07 1994-07-12 Glaxo Inc. Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone
GB9402161D0 (en) * 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
SK284810B6 (sk) * 1997-05-13 2005-12-01 Lonza Ag Spôsob výroby (1S,4R)- alebo (1R,4S)-4-(2-amino-6-chlór-9-H- purín-9-yl)-2-cyklopentén-1-metanolu

Also Published As

Publication number Publication date
BG64597B1 (bg) 2005-08-31
AR014921A1 (es) 2001-04-11
MY127470A (en) 2006-12-29
CA2306958C (en) 2007-09-04
JP2001519432A (ja) 2001-10-23
EE04059B1 (et) 2003-06-16
TR200000976T2 (tr) 2000-11-21
AU9547698A (en) 1999-05-03
HUP0003984A2 (hu) 2001-04-28
KR20010015744A (ko) 2001-02-26
NO325030B1 (no) 2008-01-21
HRP20000216B1 (en) 2002-08-31
NZ503679A (en) 2002-09-27
PL188477B1 (pl) 2005-02-28
UA54550C2 (uk) 2003-03-17
NO20001896L (no) 2000-06-13
EA200000318A1 (ru) 2000-12-25
RS49710B (sr) 2007-12-31
DK1023292T3 (da) 2003-11-10
MA24676A1 (fr) 1999-07-01
EP1023292B1 (en) 2003-09-10
CZ20001367A3 (cs) 2000-10-11
DE69818084D1 (de) 2003-10-16
IL135323A0 (en) 2001-05-20
SK5362000A3 (en) 2001-03-12
EA003183B1 (ru) 2003-02-27
CA2306958A1 (en) 1999-04-22
IN184590B (hu) 2000-09-09
WO1999019327A1 (en) 1999-04-22
DE69818084T2 (de) 2004-07-15
CZ294482B6 (cs) 2005-01-12
IS5423A (is) 2000-03-28
KR100543845B1 (ko) 2006-01-23
YU20200A (sh) 2003-02-28
BG104352A (en) 2001-02-28
PE121899A1 (es) 1999-12-20
AP2000001790A0 (en) 2000-06-30
JP4531250B2 (ja) 2010-08-25
US6646125B1 (en) 2003-11-11
ID24927A (id) 2000-08-31
OA11370A (en) 2004-01-27
HRP20000216A2 (en) 2000-08-31
EG21730A (en) 2002-02-27
IS2195B (is) 2007-01-15
SK285331B6 (sk) 2006-11-03
CO4980899A1 (es) 2000-11-27
CN1160354C (zh) 2004-08-04
BR9813048A (pt) 2000-08-15
EP1023292A1 (en) 2000-08-02
NO20001896D0 (no) 2000-04-12
CN1281457A (zh) 2001-01-24
HK1027807A1 (en) 2001-01-23
PT1023292E (pt) 2004-02-27
IL135323A (en) 2004-07-25
BR9813048B1 (pt) 2010-07-13
ES2205553T3 (es) 2004-05-01
TW436488B (en) 2001-05-28
GEP20022679B (en) 2002-04-25
ATE249461T1 (de) 2003-09-15
PL339904A1 (en) 2001-01-15
GB9721780D0 (en) 1997-12-10
ZA989338B (en) 2000-04-13
EE200000162A (et) 2001-04-16
AU738462B2 (en) 2001-09-20
AP1182A (en) 2003-06-18

Similar Documents

Publication Publication Date Title
HU9602925D0 (en) Process for the diastereoselective synthesis of nucleoside analogues
HUP0001843A3 (en) Process for synthesis of nucleoside analogs
GB9708362D0 (en) Use of vitamin C or derivatives or analogues thereof for promoting skin elastic synthesis
EP1004663A4 (en) PROCESS FOR PRODUCING PURINE NUCLEOSIDES BY FERMENTATION
HUP9901050A3 (en) Method for synthesis of dioxolane nucleosides with betha-configuration
EG20938A (en) Process for preparing of chloropurine derivatives
HUP0003984A3 (en) Process for synthesis of carbocyclyc chloropurine nucleoside analogues
IL123869A0 (en) Preparation process of nitroguanidine derivatives
AU2653200A (en) Stereoselective synthesis of nucleoside analogues
HUP9801576A3 (en) Process for the synthesis of nucleoside analogues and the intermediers
HUP9802495A3 (en) Process for producing of formyl-imidazole-derivatives
GB9400987D0 (en) Production of nucleoside analogues
GB9127243D0 (en) Synthesis of phosphorothioate analogues of oligonucleotides
SI0817784T1 (en) Process for the synthesis of nucleoside analogues
GB9816448D0 (en) Synthesis of nucleoside analogues
ZA953235B (en) Process for the diastereoselective synthesis of nucleoside analogues
SI0757684T1 (en) Process for the diastereoselective synthesis of nucleoside analogues
SI1023292T1 (en) Process for the synthesis of chloropurine intermediates
PL308803A1 (en) Method of obtaining modified p-chiral analogues of nucleotides
PL310248A1 (en) Method of obtaining modified p-chiral analogues of nucleotides
GB2309969B (en) Nucleoside analogues
GB9511288D0 (en) Use of nucleoside analogues as anticancer agents
GB9508479D0 (en) Imidazopyrimidine nucleoside analogues
GB9409904D0 (en) Imidazopyrimidine nucleoside analogues
TW346884U (en) Improved structure for typewriting holder of computer

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished